CONNECT WITH US:
Asia-Pacific has Record Year for Clinical Trials according to Novotech
SAN FRANCISCO, CA, 2020年01月14日 - (JCN Newswire) - Novotech, the largest biotech CRO in Asia Pacific, says the region has had a record year by number of studies, experienced world-class sites and investigators, and patient enrollment.
Novotech released its 'Asia-Pacific Industry Highlights 2019-2020' during the JP Morgan Healthcare Conference in San Francisco as part of its Biotech Industry Briefing session on the benefits of conducting research in Asia-Pacific.
The Biotech Industry Briefing covered:
- Asia's vast patient pools,
- High-quality infrastructure,
- Lower trial concentration,
- Comparable quality and lower costs,
- Key destination for biotech companies for later phase trials.
Novotech also spoke about the benefits of running trials with regional CRO partners in the context of multi-region trials.
Novotech CRO's Dr John Moller said "Asia-Pacific is now recognised by clinical phase biotech companies for accelerated patient enrollment - especially in rare diseases, metabolic conditions, oncology, immuno-oncology and infectious diseases - and lower clinical research costs, with some of the most experienced investigators and research teams.
"Biotech clinical research has been increasing globally by 10% per year, but in the APAC region this increase has been over 25% per year. This follows news from Australia that most clinical phase biotechs would be eligible for a 40%+ cash rebate on clinical research spend, preserved as an incentive for conducting clinical research in Australia.
"We have seen small to mid-size biotechs increasingly looking to partner with CROs of a similar size and mindset. We also found the region focused on more efficient registration and approval processes with significant improvements introduced in China and South Korea in 2019. We are ensuring our clients understand these changes which can save them valuable time and funds.
"Novotech has been expanding to meet growing demand, increasing staff by +20% in 2019, and announcing a strategic partnership with PPC Group. The partnership creates the largest biotech specialist CRO group in the Asia-Pacific, bringing together approximately 1,200 staff with significant scale and synergies across countries, research institutions, trial phases, therapeutic areas and functional specialities."
Novotech clients also have access to more than 350 clinical and operations staff across 28 cities in mainland China.
About Novotech -
Novotech, the Frost & Sullivan Asia-Pacific Biotech CRO of the Year the past 5 years, is internationally recognized as the leading Asia-Pacific full-service CRO. Established more than 20 years ago, Novotech now has 13 offices across 11 countries in APAC, and has been instrumental in the success of hundreds of Phase I-IV clinical trials in the region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, safety services, central lab services, report write-up to ICH requirements, project and vendor management.
About PPC -
PPC Group, a full-service CRO founded in 1997, offers clinical research services, laboratory and site management. PPC Group has over 600 employees, with headquarters in Shanghai and 11 offices across China, Taiwan, Japan and South Korea. PPC manages 4 Phase I Clinical Pharmacology Units, 3 Bioanalytical Labs, and a Central Laboratory.
PPC has supported more than 350 customers, performing over 500 Phase I-IV clinical trials and over 1500 generic drug bioequivalence studies. PPC is the first CRO in Asia to have undergone inspections by all major international regulatory agencies (US FDA, EU EMA, Japan's PMDA and China's NMPA), each resulting in successful client product registration.
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427
Copyright ©2020 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
NEC and Altiostar Collaborate to Advance Open vRAN Deployments for 4G and 5G
Jan 27, 2020 17:12 JST
Double Podium in Monte Carlo for New Toyota Yaris WRC Drivers
Jan 27, 2020 09:47 JST
DOCOMO Releases White Paper Promoting 6G Communication System
Jan 24, 2020 12:00 JST
NEC Develops Millimeter-wave Distributed Antenna Radio Unit Improving the Channel Quality for Indoor 5G Applications
Jan 24, 2020 11:05 JST
Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan
Jan 23, 2020 15:57 JST
Eisai: Approval of Antiepileptic Drug Fycompa in Japan for Monotherapy and Pediatric Indications for Partial-Onset Seizures, as well as a New Formulation
Jan 23, 2020 15:46 JST
Mitsubishi Corporation Participates in Vietnam's "Grand Park Project"
Jan 23, 2020 12:39 JST
Fujitsu Launches 9 New Enterprise PC Models including Educational Tablets with Improved Ease of Use
Jan 23, 2020 11:14 JST
DOCOMO to Partner with AI-powered Enterprise Meeting Note Provider Otter.ai in Japan
Jan 22, 2020 12:21 JST
DOCOMO to Pursue Collaboration with Skydio, U.S. Manufacturer of Autonomous Drones Capable of Flying without GPS Guidance
Jan 22, 2020 12:00 JST
Mitsubishi Motors concludes a disaster cooperation agreement for the first time in Tokyo with Minato City
Jan 21, 2020 20:04 JST
DOCOMO and DOCOMO ASIA to Provide IoT Solution for YANMAR's SMARTASSIST System in India
Jan 21, 2020 16:13 JST
NEC Highlights 5G-enabled Business Creation and Connectivity at MWC Barcelona 2020
Jan 20, 2020 16:08 JST
Eisai Rated "A", the Highest Rating in the CDP Climate Change Report 2019
Jan 20, 2020 15:21 JST
Fujitsu Group Earns Top Rating in CDP Climate Change Evaluation for Third Year Running
Jan 20, 2020 15:03 JST
Showa Denko to Streamline Domestic Production of Unsaturated Polyester Resin and Vinyl Ester Resin
Jan 20, 2020 12:30 JST
Toyota Indiana Completes $1.3 Billion Modernization Project; Includes 550 New Jobs
Jan 20, 2020 08:46 JST
Toyota Yaris WRC Trio Start a New Chapter with a Classic Challenge
Jan 17, 2020 20:05 JST
DOCOMO Conducts World's First Successful Trial of Transparent Dynamic Metasurface
Jan 17, 2020 16:05 JST
Hitachi Industrial Products Received "EN 15085 Certificate" for Welding of Railway Vehicles and Components
Jan 17, 2020 13:45 JST
More Latest Release >>